MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More
.
Originally reported by Psychiatry Online. Read more
Source: https://www.psychiatryonline.org/doi/full/10.1176/appi.pn.2026.04.4.3